Literature DB >> 20804663

Development of a five-year mortality model in systemic sclerosis patients by different analytical approaches.

Lorenzo Beretta1, Alessandro Santaniello, Francesca Cappiello, Nitesh V Chawla, Madelon C Vonk, Patricia E Carreira, Yannick Allanore, D A Popa-Diaconu, Marta Cossu, Francesca Bertolotti, Gianfranco Ferraccioli, Antonino Mazzone, Raffaella Scorza.   

Abstract

OBJECTIVES: Systemic sclerosis (SSc) is a multiorgan disease with high mortality rates. Several clinical features have been associated with poor survival in different populations of SSc patients, but no clear and reproducible prognostic model to assess individual survival prediction in scleroderma patients has ever been developed.
METHODS: We used Cox regression and three data mining-based classifiers (Naïve Bayes Classifier [NBC], Random Forests [RND-F] and logistic regression [Log-Reg]) to develop a robust and reproducible 5-year prognostic model. All the models were built and internally validated by means of 5-fold cross-validation on a population of 558 Italian SSc patients. Their predictive ability and capability of generalisation was then tested on an independent population of 356 patients recruited from 5 external centres and finally compared to the predictions made by two SSc domain experts on the same population.
RESULTS: The NBC outperformed the Cox-based classifier and the other data mining algorithms after internal cross-validation (area under receiving operator characteristic curve, AUROC: NBC=0.759; RND-F=0.736; Log-Reg=0.754 and Cox= 0.724). The NBC had also a remarkable and better trade-off between sensitivity and specificity (e.g. Balanced accuracy, BA) than the Cox-based classifier, when tested on an independent population of SSc patients (BA: NBC=0.769, Cox=0.622). The NBC was also superior to domain experts in predicting 5-year survival in this population (AUROC=0.829 vs. AUROC=0.788 and BA=0.769 vs. BA=0.67).
CONCLUSIONS: We provide a model to make consistent 5-year prognostic predictions in SSc patients. Its internal validity, as well as capability of generalisation and reduced uncertainty compared to human experts support its use at bedside. Available at: http://www.nd.edu/~nchawla/survival.xls.

Entities:  

Mesh:

Year:  2010        PMID: 20804663

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis.

Authors:  Wieneke Mt van den Hombergh; Hanneke Ka Knaapen-Hans; Frank Hj van den Hoogen; Patricia Carreira; Oliver Distler; Roger Hesselstrand; Nicolas Hunzelmann; Serena Vettori; Jaap Fransen; Madelon C Vonk
Journal:  J Scleroderma Relat Disord       Date:  2019-09-06

2.  Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.

Authors:  Robyn T Domsic; Svetlana I Nihtyanova; Stephen R Wisniewski; Michael J Fine; Mary Lucas; C Kent Kwoh; Christopher P Denton; Thomas A Medsger
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

3.  A prediction model for progressive disease in systemic sclerosis.

Authors:  Jessica Meijs; Anne A Schouffoer; Nina Ajmone Marsan; Theo Stijnen; Hein Putter; Maarten K Ninaber; Tom W J Huizinga; Jeska K de Vries-Bouwstra
Journal:  RMD Open       Date:  2015-12-01

4.  Applying Naive Bayesian Networks to Disease Prediction: a Systematic Review.

Authors:  Mostafa Langarizadeh; Fateme Moghbeli
Journal:  Acta Inform Med       Date:  2016-11-01

Review 5.  Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist's, Clinician's, and Patient's Perspective.

Authors:  Marta Cossu; Lorenzo Beretta; Petra Mosterman; Maria J H de Hair; Timothy R D J Radstake
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

6.  Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.

Authors:  M R Pokeerbux; J Giovannelli; L Dauchet; L Mouthon; C Agard; J C Lega; Y Allanore; P Jego; B Bienvenu; S Berthier; A Mekinian; E Hachulla; D Launay
Journal:  Arthritis Res Ther       Date:  2019-04-03       Impact factor: 5.156

7.  Update on Morbidity and Mortality in Systemic Sclerosis-Related Interstitial Lung Disease.

Authors:  Elizabeth R Volkmann; Aryeh Fischer
Journal:  J Scleroderma Relat Disord       Date:  2020-05-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.